EUVIMEDEUVIMED entdecken
Crossref

LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1

Luoshai Wang, Rongrong Ge, Hang Li, Jiazhi Yang, Juan Yao, Zhongqiu Wang

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Luoshai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Esophageal Neoplasms, N-Terminal Acetyltransferase E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNAs (lncRNAs) have been implicated in the progression of esophageal cancer (ESCA). This study investigates the oncogenic role of LINC00942 in ESCA, revealing its upregulation in tumor tissues and cell lines. Functional assays demonstrated that suppression of LINC00942 significantly reduced cell viability and tumor growth while promoting apoptosis both in vitro and in vivo using a xenograft tumor model. Mechanistically, LINC00942 silencing decreased NAT10 expression in ESCA cells and tumors, with NAT10 overexpression rescuing the inhibition of ESCA cell proliferation, migration, and invasion induced by LINC00942 knockdown, alongside a reduction in apoptosis and tumor growth inhibition. Notably, LINC00942 directly interacted with NAT10, which were co-localized in the nucleus. Further analysis indicated that NAT10 overexpression enhanced the stability and expression of HSPD1 through increased N4-acetylcytidine (ac4C) modification, thereby exerting its effects by interacting with HSPD1. These findings highlight the pivotal role of the LINC00942/NAT10/HSPD1 axis in ESCA development, suggesting it as a potential biomarker and therapeutic target for the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingEsophageal NeoplasmsN-Terminal Acetyltransferase EHumansAnimalsCell Line, TumorCell ProliferationDisease ProgressionApoptosisGene Expression Regulation, NeoplasticMice, NudeCell MovementMiceMice, Inbred BALB C

Stichwörter der Autor:innen

Esophageal cancerHSPD1LINC00942NAT10Progression

Substanzen

RNA, Long NoncodingN-Terminal Acetyltransferase E

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China.
  • Department of Oncology, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China.
  • Department of Oncology, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China. Electronic address: yaojuandoctor@163.com.
  • Department of Thoracic Surgery, Jiangsu Cancer Hospital & The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China. Electronic address: wangzhon…

Förderung

  • Jiangsu Commission of Health

Zitieren

APA

Wang, L., Ge, R., Li, H., Yang, J., Yao, J., & Wang, Z. (2026). LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112393

Vancouver

Wang L, Ge R, Li H, Yang J, Yao J, Wang Z. LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112393

BibTeX
@article{Wang2026,
  author = {Wang, Luoshai and Ge, Rongrong and Li, Hang and Yang, Jiazhi and Yao, Juan and Wang, Zhongqiu},
  title = {LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112393}
}
Kostenlos starten →